SINEs, short interspersed repeated DNA elements, undergo ampli®cation through retroposition and subsequent integration into a new location in the genome. Each new SINE insertion will be located in a new chromosomal environment, with different¯anking sequences. Modulation of transcription by different¯anking sequences may play an important role in determining which SINE elements are preferentially active in a genome. We evaluated the ability of upstream¯anking sequences to regulate the transcription of three different SINEs (Alu, B2 and ID) by constructing chimeric constructs with known 5
Introduction
SINEs are short interspersed repeated DNA elements commonly found in introns, 3
H untranslated regions of genes, and intergenic regions. Alu repeats are the major class of SINEs in the human genome. Rodents have an Alu-related element, B1, and two unrelated elements, B2 and ID (Weiner et al., 1986; Rogers, 1985) .
The SINE ampli®cation model includes the transcription of the element by RNA polymerase III (pol III), reverse transcription of the transcript, followed by integration of the cDNA into a new site in the genome (Rogers & Willison, 1983; Weiner et al., 1986; Boeke et al., 1985) . SINEs contain an internal RNA pol III promoter that consists of an A box located just downstream from the transcription start site, and a B box located approximately 50 bp downstream from the A box. In vitro transcription studies demonstrated that the internal promoter is required for transcription (Fuhrman et al., 1981; Sutcliffe et al., 1984; Kleinert et al., 1988; Willis, 1993) . Only a limited number of SINEs, termed master or source genes, appear to be capable of actively undergoing retroposition. In fact, very small amounts of SINE transcripts from limited individual elements are observed in vivo (Paulson & Schmid, 1986; Matera et al., 1990; Shaikh & Deininger, 1996; Kim et al., 1995) . The lack of in vivo transcriptional activity of most copies of the SINE elements has been attributed to a multitude of factors. Some of these factors include the stability of the RNA structure of the transcript (Labuda & Zietkiewicz, 1994) , mutations within the SINE element in¯uencing the internal promoter (Daniels & Deininger, 1991; Chu et al., 1995) , methylation (Liu & Schmid, 1993; Englander et al., 1993; Liu et al., 1994; Vorce et al., 1994) , and chromatin context (Slagel & Deininger, 1989; Englander & Howard, 1995) . Furthermore, very few SINE elements are actually capable of undergoing the retroposition process. Transcription has been suggested to be a major factor in selecting active SINEs from pseudogene copies of the SINEs (Schmid & Maraia, 1992) .
The in¯uence of upstream¯anking regions on various RNA pol III transcribed genes (Schmid & Maraia, 1992) including Alu elements and ID elements (Martignetti & Brosius, 1995) has been observed previously. reported that wild-type p53 represses pol III transcription of Alu in a promoterdependent manner. However, when they used the 7SL RNA gene upstream activating sequences or an Alu source gene with its own¯anking sequence, both relieved the p53 repression, suggesting an additional regulatory level on Alu transcription.
Our goal is to further explore the potential of upstream¯anking regions to control and enhance RNA pol III transcription of SINES. To analyze the effect of upstream¯anking regions on SINE RNA pol III transcription, we created chimeric constructs with SINEs and different¯anking sequences. We chose the upstream sequences of four known RNA pol III transcribed genes: human 7SL RNA gene (Kleinert et al., 1988) , mouse U6 RNA gene (Das et al., 1988) , rat vault RNA gene (vRNA) (Kickhoefer et al., 1993) , and the rat BC1 RNA gene (Kim et al., 1994) (Figure 1 ). The consensus sequence or a close match, all with perfect internal pol III promoters of three SINES: Alu, ID and B2 were used for the body of the chimera. Different SINEs were explored, since Alu is derived from 7SL, while ID and B2 are derived from tRNAs and their internal promoters vary. In addition, the ID elements have one particular copy, BC1, which has the unusual property of tissue speci®city, exhibiting extremely robust expression in brain and to a lesser degree in testes. To eliminate the in¯uence of the 3 H end on transcript termination and stability, all constructs contain the rat 3 H unique end from the BC1 RNA gene (Kim et al., 1994) .
Results

Enhancement of SINE transcription by upstream sequences
Transcription of the three SINES from chimeric constructs¯anked by different upstream sequences ( Figure 1 ) was evaluated by transient transfections of the human cell line HeLa (epitheloid carcinoma from cervix) and the three rodent cell lines, NIH3T3 (®broblasts), C6 (rat glial tumor), and Neuro2a (mouse neuroblastoma). Since BC1 transcription is almost exclusive to the brain, two brain-derived cell lines were chosen for transfections to evaluate any potential in¯uencing factors that may be present or absent in cells from this tissue.
The transcripts of B2 (267 bp), ID (199 bp) and Alu (370 bp) were quanti®ed from Northern blots probed with an end-labeled oligonucleotide (unique-1) complementary to the unique portion of the BC1 3 H end (Figure 1) . A constant amount of either p 7SL AluSx BC1 (for B2 and ID constructs) or p BC1 BC1 (for Alu constructs) was cotransfected as an internal control for transfection ef®ciency and used to standardize the quanti®cation (Figure 2(a) ). Transcription rates are reported as normalized values relative to the constructs carrying the BC1 upstream.
All four upstream sequences increased SINE transcription (p < 0.05 two-sided ANOVA). The SINEs without an added upstream sequence (¯anked by vector sequence) are hardly detectable above background (Figure 2(a) and (b) ). Transcription of the various SINEs varied slightly between the four cell lines, but the same general pattern of enhancement is observed. The 7SL-upstream sequence proved to be the most ef®cient, with the highest increased transcription of Alu and ID by several fold (p < 0.05). The B2 transcription from both 7SL and RVG upstream sequences appears to be comparable in strength and better than the BC1 and U6 upstream sequences. However, only the 7SL and RVG effect on B2 transcription observed in the Neuro2a cell line is signi®cantly different (p < 0.05) from the other upstream regions. Upstream enhancement strength can be indirectly H upstream region, a SINE body, and a unique 3 H end. Upstream¯anking sequences were obtained from four known RNA polymerase III transcribed genes: (1) human 7SL RNA gene (accession number M20910); (2) mouse U6 RNA gene (accession number X06980); (3) BC1 gene; and (4) rat vault RNA gene (vRNA). Flanking vector provided the sequence for the no upstream control. The SINEs BC1, B2, and the Alu with their own internal pol III promoters (A and B box) were used as bodies of the construct. The Alu body is the consensus sequence for the PS (Sx) subfamily. The ID body used matches the ID portion of the BC1 master gene (Kim et al., 1994) and for the B2 body sequence matches the B2 element within intron 4 of the murine b-glucuronidase gene (Gus-s) (Roy et al., 1998) . All constructs are¯anked at the 3 H end by the unique sequence of rat BC1 that provides the RNA pol III terminator (Kim et al., 1994) . Transcripts start at the 1 site of the SINE and end within the unique sequence of the BC1 3 H end as indicated by the arrow. The plasmids are named according to the upstream sequence (superscript) and the SINE body and the 3 H end (superscript), for example: p 7SL AluSx BC1 (7SL upstream -Alu Sx body -BC1 3 H unique sequence). The oligo``unique-1``(broken line) complementary to the BC1 unique sequence of the RNA was used as probe.
evaluated by the competition between the construct and the control plasmid, also a RNA pol IIItranscribed gene. In particular, the p In addition, SINE transcription from the different constructs was tested in vitro using HeLa extracts. The results obtained paralleled those observed using transient transfections, where the 7SL-upstream sequence proved to be the most ef®cient (data not shown).
Transcription of BC1 in a 7SL BC1 transgenic mouse line
A transgenic mouse line (G) carrying the 7SL BC1 sequence was created. Progeny of the G line-founder mouse were screened by PCR to determine the presence of the transgene, 7SL BC1. Although no detailed analyses have been made, the transgenic line appears to be normal in behavior, development and reproductive capability. In addition, we have analyzed 14 F 2 generation mice (ten male and four female transgenics produced from mating of BC1 (for Alu) and p 7SL AluSx BC1 (for BC1), and 8, no DNA transfected. Individual transcripts are indicated on the left; C, denotes the internal cotransfected control. (b) SINE constructs were transfected into four cell lines; C6 glioma (striped bar), Neuro2a (white bar), NIH3T3 (gray bar), and HeLa (black bar). Bars represent the mean AE the standard error of the mean. Note the different scales (x-axis) between Alu and BC1/B2. The upstream regions of the constructs are indicated on the x-axis (only the vector control group is shown). The expression levels were normalized to the internal controls. The ratio of the evaluated SINE transcript/control transcript was normalized to the p BC1 (SINE) transcription ratio (y-axis), which was assigned the arbitrary value of 1 (#). Statistical signi®cance calculated by the Tukey twosided Analysis of Variance (ANOVA) was used to determine p values with n > 3. * p < 0.05 statistically different from all of the groups. ** p < 0.05 statistically different from control groups. F 1 heterozygotes) by multiple breeding to detect if any were homozygous for the BC1 transgene homozygotes. We would expect one quarter of the progeny to be homozygous, but all 14 were found to be heterozygous. This may re¯ect either lethality due to higher BC1 expression levels in the homozygotes, a recessive mutation caused by the integration of the transgene, or simple chance assortment.
RNA extracts of brain, liver, kidney, spleen, intestine, testes, heart and muscle (not shown) were evaluated by Northern blot analysis with the unique-1 probe. BC1 transcripts are observed in all the transgenic mouse tissues tested (Figure 3) , in contrast to the wild-type control where BC1 is detected only in brain and testes. In order to minimize RNA degradation from some of the tissues, RNA was processed rapidly and not quanti®ed before analysis. Therefore, BC1 transcripts were quanti®ed relative to the endogenous 7SL RNA (Table 1) . However, the same general tissuespeci®c transcription pattern is observed, highest in brain (approximately ®ve times the level of 7SL RNA), followed by testes and in much smaller amounts in the rest of the tissues evaluated.
BC1-RNP complex formation in transgenic mouse tissues
BC1 RNA interacts with protein(s) to form an RNP (ribonucleoprotein) complex (Anzai & Goto, 1988; Kobayashi et al., 1991; Cheng et al., 1996) . Although the RNP proteins must be abundant in brain, the abundance or presence of these proteins in other tissues was previously unknown. We evaluated the formation of the BC1 RNP complex in several different tissues from the transgenic mouse.`N ative mobility shift assays'' for the endogenous RNP from extracts of brain, liver, kidney, heart, and testes were probed for BC1 RNA (Figure 4 ). BC1 RNP is detected in large amounts in brain, in smaller amounts in testes, liver, heart and spleen (not shown), and barely detectable in kidney when samples are equalized by protein concentration (Figure 4 
Discussion
The vast majority of Alu elements are incapable of making copies (Paulson & Schmid, 1986; Liu & Schmid, 1993) . The same could be true for other SINE families as well (Kim et al., 1995; Deragon et al., 1996) . Since most SINE elements are very similar in sequence, it seems likely that major in¯u-ences on whether a SINE is active or not reside in the¯anking sequences of speci®c elements, which will differ for each individual element insertion. The BC1 RNA gene, an ID SINE element, is the only identi®ed SINE that has served as an ef®cient`m aster'' element for SINE ampli®cation over a long period of time. Since transcription is required for retroposition, and the BC1 RNA gene is highly BC1 transgenic and wild-type mice. Total RNA from different tissues was hybridized with BC1 (unique-1) and 7SL (a7SL-1) speci®c oligos: 1, brain; 2, liver; 3, kidney; 4, spleen; 5, intestine; 6, testes; and 7, heart. (Martignetti & Brosius, 1995; Kobayashi & Anzai, 1998 ) and a number of other RNA pol III-transcribed genes (Ullu & Weiner, 1985) . Our analysis, using several chimeric constructs, further corroborates the importance of the upstream¯anking sequence in the control and in¯uence of RNA pol III transcription of SINEs. These results showed that these SINEs, regardless of tRNA or 7SL origin, responded approximately the same to the various upstream sequences. In addition, similar activation occurred, regardless of the cell type transfected. Thus, the activator sequences appear to be fairly generic and lead to ubiquitous expression patterns. Previous analyses of these four upstream sequences suggested the presence of cis-acting upstream elements affecting their transcription i.e. PSE, SP1, ATF, OCT or DSE (Bredow et al., 1990; Martignetti & Brosius, 1995; Carbon et al., 1987; Danzeiser et al., 1993; Kickhoefer et al., 1993) . In addition, TATA-like elements are present in three of the upstream sequences used. The 7SL upstream sequence has no real TATA box, but has a TAGTA that may be a functional binding site (Bredow et al., 1990) . These upstream cis-acting elements present in the constructs may provide an advantage to the RNA poly III internal promoter by recruiting transcription factors to the site.
The upstream sequence regulates BC1 transcription in vivo
RNA poly III-transcribed RNAs are generally ubiquitously expressed, making the tissue-speci®city of the BC1 RNA quite unusual. We considered the possibility that RNA poly III transcription of the BC1 RNA gene was ubiquitous, but that the RNA expression was primarily regulated post-transcriptionally. In our 7SL BC1 transgenic mice, the expression of the rat BC1 transgene in all tissues con®rms that the RNA is at least reasonably stable in other tissues. Although we obtained only one founder mouse, it is doubtful that our results are in¯uenced greatly by a``position'' effect. Our goal was to eliminate the BC1 tissue-speci®c regulation. Therefore, we utilized an upstream region from a constitutively expressing gene, 7SL, to try to disrupt the normal regulation. Because we obtained expression in every tissue tested, this allowed us to demonstrate that BC1 is stable, and makes a similar protein complex in all tissues tested. Although the expression is now constitutive, we continue to see the same neuronal and testes-speci®c expression preference in the transgene as for the endogenous gene. This would be extremely unlikely to be caused by a fortuitous integration site that mimics the endogenous gene and almost certainly demonstrates a post-transcriptional component to the regulation. Finally, it is worth considering the potential in¯uence of multiple copies of the transgene. As there are already more than 10,000 BC1 closely related elements in the mouse genome, copy number of the repetitive portion of the element is very unlikely to have any in¯uence. In general, multiple copies of the upstream portion could be considered to titrate out Modulation of SINE Transcription speci®c factors. However, since we are using the upstream region to drive constitutive expression, it seems unlikely that we could mimic the endogenous regulation. Therefore the primary repression of the endogenous BC1 gene in those tissues must be predominantly at the level of transcription.
These data con®rm previous work utilizing in vitro transcription that suggested transcriptional speci®city (Martignetti & Brosius, 1995) . Work on another BC1 transgenic mouse line (containing the BC1 RNA gene 1.4 kb SacI-BamHI fragment) suggests that its endogenous upstream sequence contains suf®cient information to direct tissuespeci®c transcription (Martignetti & Brosius, 1995) . In addition, one of the ®ve E-boxes, (pol II enhancer element and binding site for myogenic factors of the MyoD family) apparently necessary for effective transcription of BC1, was recognized speci®cally by brain nuclear protein(s) (Kobayashi & Anzai, 1998) . The authors suggest that the upstream E-box and its binding protein may be involved in the regulation of the preferential RNA pol III BC1 expression in brain.
Although the rat BC1 transgene is expressed in all tissues, a tissue-speci®c pattern is maintained. Stability of the transcript may be the cause for the differential expression of BC1 in the tissues. Because the endogenous BC1 and the rat BC1 transgene transcripts are almost identical (only two bases different) something other than the basic primary sequence and structure may be involved in BC1 RNA stability. Increased BC1 stability in brain may be due to the compartmentalization of the BC1 RNA to the dendrites (Tiedge et al., 1991 (Tiedge et al., , 1991 Muslimov et al., 1997) ; thus removing the BC1 RNA from the normal degradation pathway. Alternatively, the protein interaction with RNA may provide protection from degradation. Several proteins have been suggested as candidates through in vitro analyses, but have not been directly linked to the endogenous complex (Kobayashi et al., 1992a,b; Muramatsu et al., 1998; Kremerskothen et al., 1998) . Our``native mobility shift assays'' demonstrate that the BC1 RNA in some of the tissues of the transgenic mouse tested was present as an RNP complex. All the RNP complexes observed appear to be the same as the one present in the brain of the wild-type mouse. Although we cannot rule out that different tissues have different members of a closely related family of RNA binding proteins, it seems likely that the RNA binding protein(s) may be of a ubiquitous nature and have a function other than forming a complex with BC1 RNA. In addition, the proteins are unlikely to be involved in a purely neural function. It is interesting that no free BC1 RNA was observed in our native mobility shift assays, even when overexpressed to very large amounts in brain (Figure 4(a) ). There are several potential explanations for this observation. First, the protein normally may be expressed in large amounts, making it available to form the complex upon the transcription of BC1. Alternatively, the increased expression of BC1 may indirectly force the cell to upregulate the proteins' expression by sequestering them from their normal function. Finally, the amount of the protein may dictate the amount of RNP complex made, with the prompt degradation of any free BC1 RNA.
Previous reports suggest that the autoantigen, La, may be part of this RNP complex (Kremerskothen et al., 1998) . We have been unable to precipitate the BC1 RNA with anti-La antibodies (data not shown). It is possible that the appropriate epitopes are not exposed in the RNP complex. La is ubiquitously expressed with nuclear localization (Keech et al., 1993; Bachmann et al., 1997) . Such published data seem inconsistent with the extremely high levels of complex that are present in the brain cytoplasm. Thus, although we believe that La probably associates with the BC1 RNA transiently, it seems unlikely that it is part of the cytoplasmic RNP complex that we observe.
Upstream modulation of general SINE transcription and potential role in retroposition
Optimal¯anking sequences that allow SINEs to express strongly are probably rare. We do not yet know enough about RNA poly III upstream activating sequences to know how position and orientation affect transcription ef®ciency. In addition to a paucity of genomic activating sites, it is also likely that there is a strong selection against expression of SINEs, because a strongly transcribing element may result in a high level of deleterious mutations through retroposition. In addition, high levels of expression may be disruptive to cell function by competing for RNA binding proteins, or in¯uencing processes such as translation, as has been suggested for Alu (Chu et al., 1998) .
The origin and evolution of BC1 RNA expression
The BC1 RNA gene shows sequence and expression conservation consistent with a gene under functional selection . Thus, the BC1 RNA gene has``exapted'' (Brosius & Gould, 1992) to some function following its formation in the rodent genome. It may be the fortuitous formation or insertion of the BC1 element adjacent to upstream activating sequences that allowed it to express and both initiate the ID family of SINEs and continue to serve as a master element for ampli®cation throughout the rodent lineage (Kim et al., 1994) . In a case like this, where an element begins to express to high levels, it is important that the expression does not compete with normal cellular functions (i.e. sequester key RNA binding proteins that are needed for other RNAs). In the case of BC1, this may have been helped by the tissue speci®city of the expression, directing the RNA to tissues that could best accommodate the high level of the RNA. It seems likely that BC1 RNA expression was originally fairly ubi-quitous, but that its regulation quickly evolved to allow expression where the RNA would have the least negative impact and that it gradually exapted to having a positive role in those tissues.
Materials and Methods
Construction of plasmids
Constructs containing different upstream sequences of known RNA poly III transcribed genes (7SL, U6, RVG, and BC1) were cloned upstream of three different SINEs (B2, rat BC1, and Alu) all with the unique 3 H end from the mouse BC1 master gene, see Figure 1 . The plasmids are named according to the upstream sequence (superscript), the SINE body, and the 3 H end (superscript), for example:
. The particular Alu body is the consensus sequence for the PS (Sx) subfamily. The ID body used exactly matches the ID portion of the BC1 master gene (Kim et al., 1994) and for the B2 body, the sequence used (a close match to the consensus) is from the B2 element within intron 4 of the murine bglucuronidase gene (Gus-s) (Roy et al., 1998) . Upstream sequences, individual SINEs and the BC1 3 H downstream sequence were individually ampli®ed and joined by PCR using overlapping primers (Ling & Robinson, 1997) . The ®nal PCR product of the complete construct was cloned into the pCRII or pCRII.1 vector of the TA cloning kit (InVitrogen). Evaluation of both strands by sequencing con®rmed the correct sequences of the constructs. Puri®ed plasmids were prepared by alkaline lysis of bacterial cells followed by banding twice in a CsCl gradient. DNA concentrations were determined spectrophotometrically by using A 260 and veri®ed by visual examination of ethidium bromide-stained agarose gels.
Transcription in cell lines
Transient transfections were carried out in the human cell line HeLa (ATCC CCL2), and the rodent cell lines Neuro2a (ATCC CCL131), NIH3T3 (ATCC CRL1658), and C6 glioma (ATCC CCL107). Monolayers were grown to 40-60 % con¯uency and transfected with 10 mg of the construct-containing plasmid and 2 mg of control plasmid using LipofectAmine 1 (Gibco Life Sciences) following the manufacturer's recommended protocol. Total RNA was isolated 16-20 hours post-transfection.
DNA and RNA analysis
Genomic DNA was isolated from mouse tails using the Easy DNA 2 kit (InVitrogen) following the manufacturer's recommended protocol. Selected tissues were removed from euthanized mice and immediately processed. RNA was extracted from cell lines and mouse tissues utilizing the Trizol 2 Reagent (Life Technologies, Inc.) according to the manufacturer's protocol. Equal amounts of RNA were electrophoresed on a 2 % agaroseformaldehyde gel and then transferred to a nylon membrane, Hybond-N (Amersham). Northern blots were hybridized utilizing one or both of the following endlabeled DNA oligos: unique-1 5 H -TGTGTGTGCCAGT-TACCTTG-3 H (complementary to the unique region of the BC1 RNA) and a7SL 5
H -CCGATCGGCATAGCG-CACTA-3 H (complementary to a region of the 7SL RNA that does not share sequence similarity to Alu RNA) in 5Â SSC, 5Â Denhardt's, 1 % (w/v) SDS and 100 mg/ml herring sperm DNA. Oligonucleotides were end-labeled with [g-32 P]ATP (Amersham) using T4 polynucleotide kinase (NEB), and puri®ed by ®ltration through a Sephadex G-50 column. Blots were washed thrice at 42 C with a low stringency buffer (2Â SSC and 1 % (w/v) SDS) and subjected to autoradiography or quanti®ed using a Phosphorimager screen and ImageQuant Software (Molecular Dynamics). Statistical analysis was performed using the Jandel SigmaStat Statistical Software Version 2, Jandel Corporation.
Transgenic mouse production
Transgenic mice were produced by Chrysalis DNX Transgenic Sciences Corporation (Princeton, NJ, USA). A 385 bp EcoRI fragment containing the complete 7SL BC1 unit was microinjected into C57BL/6 Â SJLF2 hybrid mouse eggs. Transgenic mice were identi®ed by PCR analysis of tail DNA with transgene-speci®c primers. The primers used were 5
H -CCTCCAGACCGCC-CAGTGTGGGTGT-3 H (for the upstream 7SL region), and 5 H -GATACTGCGATATCCTAAAGGGCAG-3 H (for the BC1 3 H end). Ampli®cation was performed in an MJ thermal cycler using 50 pmol of each of the primers for ®ve cycles as follows: 94 C, 58 C, and 72 C each for 30 seconds, followed by 25 cycles at 94 C, 46 C, and 72 C for 30 seconds each. The ®nal chain extension step was at 72 C for ®ve minutes. Only one line, referred to as the G line, was established containing the transgene. Transcription of the transgene in the selected tissues was detected by Northern blot analysis and RT-PCR with subsequent sequencing of the cDNA.
Native mobility shift assay
Cytoplasmic extracts were obtained by differential centrifugation as previously described (Cheng et al., 1996; Kobayashi et al., 1992a) with minor modi®cations. In brief, tissue (0.5 g/ml of buffer) was homogenized in buffer: 100 mM KCl, 15 mM MgCl 2 , 10 mM Tris (pH 7.5), 0.32 M sucrose, 0.2 mM PMSF, 1 mM DTT, 0.1 % (w/v) aprotinin and 1.5 ml/g tissue of protease inhibitor cocktail (SIGMA). Samples were centrifuged at 2000 g for ®ve minutes, followed by a second spin of the supernatant at 15,000 g for ten minutes. The supernatant was further cleared by centrifugation at 105,000 g for two hours. Finally, glycerol was added to the supernatant to a ®nal concentration of 20 % (v/v). Samples of the tissue extracts were electrophoresed in high ionic non-denaturing polyacrylamide gels as described previously (Ausubel et al., 1996) . The gels were transferred to zetaprobe blotting membrane (Bio-Rad) in Tris-glycine buffer (0.05 M Tris, 0.375 M glycine, 2 mM EDTA (pH 8.5)) for one hour at 350 mA. UV-crosslinked membranes were hybridized with end-labeled unique-1 oligo under the same conditions described above.
